Premium
Reiter syndrome triggered by adalimumab (Humira ® ) and leflunomide (Arava ® ) in a patient with ankylosing spondylarthropathy and Crohn disease
Author(s) -
Thielen A.M.,
Barde C.,
Janer V.,
Borradori L.,
Saurat J.H.
Publication year - 2007
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2006.07586.x
Subject(s) - medicine , adalimumab , dermatology , infliximab , pathology , gastroenterology , disease